Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Symonds

Showing results (181-190 of 324) with videos related to

Pageof 33
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2018
Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer PatientsK Johnson, J Chang-Claude, A-M Critchley, et al.
British Journal of Cancer|December 17, 2003
Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivityM A L Moneef, B T Sherwood, K J Bowman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancerR P Symonds, T Habeshaw, N S Reed, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancerB T Sherwood, A J Colquhoun, D Richardson, et al.
British Journal of Cancer|May 23, 2013
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancerM McCormack, L Kadalayil, A Hackshaw, et al.
Molecular Therapy. Methods & Clinical Development|March 10, 2016
Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDSChristopher W Peterson, Kevin G Haworth, Bryan P Burke, et al.
International Journal of Molecular Sciences|December 29, 2012
Dendritic cells and multiple sclerosis: disease, tolerance and therapyMohammad G Mohammad, Masoud Hassanpour, Vicky W W Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials GroupP A Vasey, J Paul, A Birt, et al.
The Journal of Gene Medicine|January 19, 2005
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patientsJanet L Macpherson, Maureen P Boyd, Allison J Arndt, et al.
British Journal of Cancer|July 7, 2012
A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapyC J Talbot, G A Tanteles, G C Barnett, et al.
Pageof 33

Showing results (181-190 of 324) with videos related to

Sort By:
Pageof 33
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2018
Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer PatientsK Johnson, J Chang-Claude, A-M Critchley, et al.
British Journal of Cancer|December 17, 2003
Measurements using the alkaline comet assay predict bladder cancer cell radiosensitivityM A L Moneef, B T Sherwood, K J Bowman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
The Scottish and Manchester randomised trial of neo-adjuvant chemotherapy for advanced cervical cancerR P Symonds, T Habeshaw, N S Reed, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Carbonic anhydrase IX expression and outcome after radiotherapy for muscle-invasive bladder cancerB T Sherwood, A J Colquhoun, D Richardson, et al.
British Journal of Cancer|May 23, 2013
A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancerM McCormack, L Kadalayil, A Hackshaw, et al.
Molecular Therapy. Methods & Clinical Development|March 10, 2016
Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDSChristopher W Peterson, Kevin G Haworth, Bryan P Burke, et al.
International Journal of Molecular Sciences|December 29, 2012
Dendritic cells and multiple sclerosis: disease, tolerance and therapyMohammad G Mohammad, Masoud Hassanpour, Vicky W W Tsai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials GroupP A Vasey, J Paul, A Birt, et al.
The Journal of Gene Medicine|January 19, 2005
Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patientsJanet L Macpherson, Maureen P Boyd, Allison J Arndt, et al.
British Journal of Cancer|July 7, 2012
A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapyC J Talbot, G A Tanteles, G C Barnett, et al.
Pageof 33